| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8454577 | Lung Cancer | 2016 | 7 Pages |
Abstract
We developed a serum mass profile-based signature identifying patients with early lung cancer. Although this marker has insufficient value as a stand-alone preselecting tool for LD-CT screening, its potential clinical usefulness in evaluation of indeterminate pulmonary nodules deserves further investigation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Piotr Widlak, Monika Pietrowska, Joanna Polanska, Michal Marczyk, Malgorzata Ros-Mazurczyk, RafaÅ Dziadziuszko, Jacek Jassem, Witold Rzyman,